United Capital Financial Advisers, LLC Sorrento Therapeutics, Inc. Transaction History

United Capital Financial Advisers, LLC

  • $19.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 17, 2021
SELL
$5.76 - $11.95 $154,396 - $320,319
-26,805 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$6.17 - $18.82 $82,091 - $250,400
13,305 Added 98.56%
26,805 $299,000
Q2 2020

Aug 13, 2020
BUY
$1.73 - $6.76 $23,355 - $91,260
13,500 New
13,500 $85,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email